Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances

OBJECTIVES: Alteplase is commonly recommended for acute ischaemic stroke within 4.5 hours after stroke onset. The Third European Cooperative Acute Stroke Study (ECASS III) is the only trial reporting statistically significant efficacy for clinical outcomes for alteplase use 3–4.5 hours after stroke...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMJ Evid Based Med
Main Authors: Alper, Brian Scott, Foster, Gary, Thabane, Lehana, Rae-Grant, Alex, Malone-Moses, Meghan, Manheimer, Eric
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2020
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7548536/
https://ncbi.nlm.nih.gov/pubmed/32430395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjebm-2020-111386
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares